+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

InSightec Ltd - Product Pipeline Analysis, 2022 Update

  • PDF Icon

    Company Profile

  • 43 Pages
  • February 2023
  • GlobalData
  • ID: 5739987
InSightec Ltd (InSightec) a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens' health. Its services include commercial development advisory, free professional services, free platform upgrade, onsite support, parts warranty, periodic maintenance, onsite clinical training, business support, customer services, remote technical support and software upgrades. InSightec's products are used by physicians in medical facilities in the treatment of tumor. It operates in China, Israel, Japan and the UK. InSightec is headquartered in Tirat Carmel, Israel.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company InSightec Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • InSightec Ltd Company Overview
  • InSightec Ltd Company Snapshot
  • InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • InSightec Ltd - Pipeline Analysis Overview
  • InSightec Ltd - Key Facts
  • InSightec Ltd - Major Products and Services
  • InSightec Ltd Pipeline Products by Development Stage
  • InSightec Ltd Ongoing Clinical Trials by Trial Status
  • InSightec Ltd Pipeline Products Overview
  • ExAblate - Brain Cancer
  • ExAblate - Brain Cancer Product Overview
  • ExAblate - Brain Cancer Clinical Trial
  • ExAblate - Liver Cancer
  • ExAblate - Liver Cancer Product Overview
  • ExAblate - Metastatic Breast Cancer
  • ExAblate - Metastatic Breast Cancer Product Overview
  • ExAblate Neuro
  • ExAblate Neuro Product Overview
  • ExAblate Neuro Clinical Trial
  • Exablate Neuro - Alzheimer’s Disease
  • Exablate Neuro - Alzheimer’s Disease Product Overview
  • Exablate Neuro - Alzheimer’s Disease Clinical Trial
  • Exablate Neuro System - NSCLC
  • Exablate Neuro System - NSCLC Product Overview
  • InSightec Ltd - Key Competitors
  • InSightec Ltd - Key Employees
  • InSightec Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • InSightec Ltd, Recent Developments
  • Jan 31, 2023: Insightec announces positive coverage decision by cigna for focused ultrasound to treat essential tremor
  • Nov 24, 2020: INSIGHTEC announces MR-guided focused ultrasound to treat essential tremor received funding by National Health Service (NHS) England
  • Oct 29, 2020: Lantheus enters into strategic collaboration with Insightec for use of microbubbles in combination with MR-Guided Focused Ultrasound for Treatment of Glioblastoma and Neurodegenerative Conditions
  • Mar 09, 2020: Insightec raises $150m to support treatment of movement disorders
  • Jan 23, 2020: INSIGHTEC has received a Pre-Market Approval (PMA) for its Exablate Neuro from the Japanese Ministry of Health Labor and Welfare (MHLW).
  • Jul 10, 2019: INSIGHTEC receives FDA approval and CE Mark for Exablate Neuro with GE SIGNA Premier MR System
  • Jun 02, 2019: Insightec focused ultrasound receives reimbursement from Japanese MHLW for the treatment of Essential Tremor
  • May 06, 2019: Clinical trial explores opening blood-brain barrier in fight against Alzheimer's
  • Feb 25, 2019: INSIGHTEC announces expansion of positive insurance coverage for MR-guided focused ultrasound to treat essential tremor
  • Jan 31, 2019: Insightec announces first glioblastoma patient completed chemotherapy cycles with BBB disruption using focused ultrasound in Yonsei University
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • InSightec Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • InSightec Ltd Pipeline Products by Equipment Type
  • InSightec Ltd Pipeline Products by Indication
  • InSightec Ltd Ongoing Clinical Trials by Trial Status
  • InSightec Ltd, Key Facts
  • InSightec Ltd, Major Products and Services
  • InSightec Ltd Number of Pipeline Products by Development Stage
  • InSightec Ltd Pipeline Products Summary by Development Stage
  • InSightec Ltd Ongoing Clinical Trials by Trial Status
  • InSightec Ltd Ongoing Clinical Trials Summary
  • ExAblate - Brain Cancer - Product Status
  • ExAblate - Brain Cancer - Product Description
  • ExAblate - Brain Cancer - A Safety and Feasibility Study to Evaluate Blood Brain Barrier Disruption Using Exablate MR Guided Focused Ultrasound in Combination With Doxorubicin in Treating Pediatric Patients with Diffuse Intrinsic Pontine Gliomas (DIPG)
  • ExAblate - Brain Cancer - A Study to Evaluate the Safety and Feasibility of Blood-brain Barrier Disruption Using Transcranial MRI-guided Focused Ultrasound with Intravenous Ultrasound Contrast Agents in the Treatment of Brain Tumours with Doxorubicin
  • ExAblate - Liver Cancer - Product Status
  • ExAblate - Liver Cancer - Product Description
  • ExAblate - Metastatic Breast Cancer - Product Status
  • ExAblate - Metastatic Breast Cancer - Product Description
  • ExAblate Neuro - Product Status
  • ExAblate Neuro - Product Description
  • ExAblate Neuro - A Clinical Study to Investigate the Safety and Efficacy of Exablate Neuro for glioblastoma treatment
  • ExAblate Neuro - A Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
  • ExAblate Neuro - A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients with Opioid Use Disorder (OUD)
  • ExAblate Neuro - A Feasibility Study of MRgFUS in the Treatment of Therapy-Resistant Tremor-Related Patients with Low SDR Value
  • ExAblate Neuro - A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using the ExAblate Transcranial System to Treat the Cardinal Motor Features of Parkinson's Disease
  • ExAblate Neuro - A Feasibility Study to Evaluate Safety and Initial Effectiveness of MR-Guided Focused Ultrasound Ablation Therapy in the Treatment of Focal Epilepsy
  • ExAblate Neuro - A Pilot Study for Brain Delivery of Cerezyme in Patients with Parkinson's Disease Using MR-guided Focused Ultrasound Induced Opening of the Blood-brain Barrier
  • ExAblate Neuro - A Pivotal Clinical Trial of the Management of the Medically-refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Idiopathic Parkinson's Disease with Unilateral Lesioning of the Globus Pallidum Using the ExAblate Neuro System
  • ExAblate Neuro - A Pivotal Study Evaluating the Efficacy of Exablate Neuro System in the Treatment of Patients with Primary Non-small Cell Lung Cancer: LIMITLESS
  • ExAblate Neuro - A Study to Evaluate the Effectiveness and Safety of Exablate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
  • ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Disruption (BBBD) with Microbubbles for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy
  • ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Blood-brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy
  • ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Disruption for the Treatment of High-grade Glioma in Patients Undergoing Standard Chemotherapy
  • ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Blood-brain Barrier Open (BBB Open) with Microbubble Resonators for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy (Clinical Research for BBB Open)
  • ExAblate Neuro - Assessment of Safety and Feasibility of ExAblate Neuro System to Perform Auto-focusing Echo Imaging in Patients with Idiopathic Essential Tremor with Medication Refractory Tremor
  • ExAblate Neuro - Assessment of Safety and Feasibility of Exablate Neuro System to Perform Echo-Focusing Echo Imaging in Patients with Treatment-Resistant Neurologic and Psychiatric Indications
  • ExAblate Neuro - Phase 1 Clinical Trial for MR Guided Focused Ultrasound (FUS) Thalamotomy of Central Lateral Thalamic Nucleus for the Treatment of Medication-refractory Trigeminal Neuralgia
  • ExAblate Neuro - Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy for Pain Palliation in Head & Neck Cancer
  • ExAblate Neuro - Transcranial Ultrasound Therapy of Essential Tremor
  • Exablate Neuro - Alzheimer’s Disease - Product Status
  • Exablate Neuro - Alzheimer’s Disease - Product Description
  • Exablate Neuro - Alzheimer’s Disease - A Phase IIa Study to Evaluate the Safety and Efficacy of Blood-Brain Barrier (BBB) Opening Using Transcranial MR-guided Focused Ultrasound in Patients with Alzheimer's Disease
  • Exablate Neuro - Alzheimer’s Disease - Assessment of Safety and Efficacy of ExAblate Blood-brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease
  • Exablate Neuro System - NSCLC - Product Status
  • Exablate Neuro System - NSCLC - Product Description
  • InSightec Ltd, Key Employees
  • InSightec Ltd, Other Locations
  • Glossary
List of Figures
  • InSightec Ltd Pipeline Products by Equipment Type
  • InSightec Ltd Pipeline Products by Development Stage
  • InSightec Ltd Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • WideMed Technologies LTD
  • Trig Medical Ltd
  • Alma Lasers Ltd
  • WideMed Technologies LTD
  • Trig Medical Ltd
  • Alma Lasers Ltd